| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
58,241 |
53,004 |
$3.83M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
9,383 |
9,335 |
$958K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,182 |
8,740 |
$783K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
6,910 |
6,814 |
$683K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
9,454 |
9,254 |
$359K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,214 |
9,085 |
$155K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,277 |
1,258 |
$133K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,975 |
7,639 |
$131K |
| 99050 |
|
13,495 |
13,082 |
$112K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,110 |
2,091 |
$83K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,152 |
2,070 |
$67K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,838 |
1,832 |
$40K |
| 90674 |
|
1,004 |
999 |
$29K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
245 |
243 |
$26K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,383 |
2,317 |
$21K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
125 |
125 |
$19K |
| 71046 |
Radiologic examination, chest; 2 views |
897 |
878 |
$18K |
| 80053 |
Comprehensive metabolic panel |
1,199 |
1,189 |
$14K |
| 99051 |
|
426 |
423 |
$13K |
| 36415 |
Collection of venous blood by venipuncture |
4,441 |
4,152 |
$13K |
| 81003 |
|
7,341 |
7,132 |
$12K |
| 80050 |
General health panel |
230 |
229 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
222 |
222 |
$11K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
107 |
107 |
$11K |
| 93000 |
|
815 |
810 |
$11K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
545 |
533 |
$10K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,913 |
1,893 |
$10K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,037 |
1,033 |
$10K |
| 99233 |
Prolong inpt eval add15 m |
69 |
39 |
$8K |
| 90688 |
|
591 |
587 |
$8K |
| 80061 |
Lipid panel |
379 |
376 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
526 |
513 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
24 |
24 |
$5K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
48 |
48 |
$5K |
| 72100 |
|
146 |
145 |
$4K |
| 90686 |
|
306 |
305 |
$4K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
351 |
349 |
$4K |
| 90661 |
|
117 |
117 |
$4K |
| 74019 |
|
121 |
120 |
$3K |
| 73562 |
|
110 |
92 |
$3K |
| 81025 |
|
304 |
298 |
$3K |
| 92587 |
|
129 |
128 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,413 |
2,323 |
$2K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
34 |
12 |
$2K |
| 99223 |
Prolong inpt eval add15 m |
12 |
12 |
$2K |
| 84439 |
|
166 |
164 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,785 |
2,749 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
30 |
30 |
$1K |
| 87807 |
|
56 |
56 |
$690.14 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
14 |
14 |
$646.20 |
| 73630 |
|
28 |
24 |
$591.48 |
| 73130 |
|
39 |
29 |
$573.30 |
| 90694 |
|
161 |
158 |
$536.31 |
| 94010 |
|
18 |
18 |
$532.35 |
| 98966 |
|
53 |
50 |
$528.17 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
14 |
14 |
$521.11 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
14 |
14 |
$510.07 |
| 84443 |
Thyroid stimulating hormone (TSH) |
24 |
24 |
$446.51 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
771 |
737 |
$433.09 |
| 99080 |
|
43 |
43 |
$388.76 |
| 94664 |
|
33 |
33 |
$388.76 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
14 |
14 |
$358.19 |
| 73030 |
|
14 |
12 |
$315.53 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
86 |
86 |
$188.29 |
| 90662 |
|
26 |
25 |
$177.81 |
| G0008 |
Administration of influenza virus vaccine |
325 |
316 |
$117.37 |
| 90653 |
|
19 |
19 |
$67.43 |
| 82962 |
|
15 |
14 |
$34.72 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
561 |
545 |
$27.82 |
| 36416 |
|
32 |
32 |
$2.25 |
| 90649 |
|
12 |
12 |
$0.09 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
13 |
12 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
66 |
65 |
$0.00 |
| 1160F |
|
32 |
29 |
$0.00 |
| 3078F |
|
13 |
13 |
$0.00 |
| 1125F |
|
2,382 |
2,193 |
$0.00 |
| 1126F |
|
2,373 |
2,185 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
87 |
86 |
$0.00 |